Astrana Health公司(ASTH)今日盘中大涨5.44%,引发市场广泛关注。
从分析师评级来看,百瑞德维持该公司股票评级为"优于大市",但将目标价从86美元下调至50美元。此外,TD Cowen也将Astrana Health的目标价从66美元下调至40美元。
尽管分析师下调了对该公司的目标价,但仍对其前景保持乐观评级,这可能是引发投资者追捧、股价短期内大涨的主因。市场或认为此前该股的估值偏高,分析师调低目标价修正了之前的过度预期,导致其当前价格回到合理区间,从而刺激交易量增加、引发股价快速上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.